PF-06650833

Generic Name: PF-06650833

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₂₀FN_₃O_₄

CAS Number: 1817626-54-2

Unique Ingredient Identifier: S3F315JJXI

Background: PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-06650833
Drug: Placebo

First Posted Date: 2014-08-25

Last Posted Date: 2015-07-02

Lead Sponsor: Pfizer

Target Recruit Count: 40

Registration Number: NCT02224651

Locations: 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy